The genetics and biochemistry of isoniazid resistance in Mycobacterium tuberculosis

被引:161
|
作者
Slayden, RA [1 ]
Barry, CE [1 ]
机构
[1] NIAID, TB Res Sect, Host Def Lab, NIH, Rockville, MD 20852 USA
关键词
isoniazid; KatG; catalase; tuberculosis; pro-drug;
D O I
10.1016/S1286-4579(00)00359-2
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Although the primary targets of activated isoniazid (INH) are proteins involved in the biosynthesis of cell wall mycolic acids, clinical resistance is dominated by specific point mutations in katG. Mutations associated with target mutations contribute to, but still cannot completely explain, resistance ro INH. Despite the wealth of genetic information currently available, the molecular mechanism of cell death induced by INH remains elusive. (C) 2000 Editions scientifiques et medicales Elsevier SAS.
引用
收藏
页码:659 / 669
页数:11
相关论文
共 50 条
  • [1] Mechanisms of isoniazid resistance in Mycobacterium tuberculosis
    Barry, CE
    Slayden, RA
    Mludli, K
    [J]. DRUG RESISTANCE UPDATES, 1998, 1 (02) : 128 - 134
  • [2] THE SIGNIFICANCE OF RESISTANCE OF MYCOBACTERIUM TUBERCULOSIS TO ISONIAZID
    JOHNSTON, RN
    RIDDELL, RW
    [J]. AMERICAN REVIEW OF TUBERCULOSIS, 1954, 70 (03): : 442 - 452
  • [3] ISONIAZID RESISTANCE IN MYCOBACTERIUM-TUBERCULOSIS
    BLANCHARD, JS
    QUEMARD, A
    SACCHETTINI, J
    JACOBS, WR
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1994, 208 : 13 - BIOL
  • [4] Acetylation of Isoniazid Is a Novel Mechanism of Isoniazid Resistance in Mycobacterium tuberculosis
    Arun, K. B.
    Madhavan, Aravind
    Abraham, Billu
    Balaji, M.
    Sivakumar, K. C.
    Nisha, P.
    Kumar, R. Ajay
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (01)
  • [5] The molecular basis of isoniazid resistance in Mycobacterium tuberculosis
    Heym, B
    [J]. MULTI-DRUG RESISTANCE IN EMERGING AND RE-EMERGING DISEASES, 2000, : 97 - 108
  • [6] HAEMIN AND ISONIAZID RESISTANCE OF MYCOBACTERIUM-TUBERCULOSIS
    KNOX, R
    [J]. JOURNAL OF GENERAL MICROBIOLOGY, 1955, 12 (02): : 191 - 202
  • [7] REVERSIBILITY OF ISONIAZID RESISTANCE DEVELOPED IN MYCOBACTERIUM TUBERCULOSIS
    INCZE, JS
    [J]. DISEASES OF THE CHEST, 1954, 26 (02): : 127 - 132
  • [8] Chemical disarming of isoniazid resistance in Mycobacterium tuberculosis
    Flentie, Kelly
    Harrison, Gregory A.
    Tukenmez, Hasan
    Livny, Jonathan
    Good, James A. D.
    Sarkar, Souvik
    Zhu, Dennis X.
    Kinsella, Rachel L.
    Weiss, Leslie A.
    Solomon, Samantha D.
    Schene, Miranda E.
    Hansen, Mette R.
    Cairns, Andrew G.
    Kulen, Martina
    Wixe, Torbjorn
    Lindgren, Anders E. G.
    Chorell, Erik
    Bengtsson, Christoffer
    Krishnan, K. Syam
    Hultgren, Scott J.
    Larsson, Christer
    Almqvist, Fredrik
    Stallings, Christina L.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2019, 116 (21) : 10510 - 10517
  • [9] Overview on mechanisms of isoniazid action and resistance in Mycobacterium tuberculosis
    Unissa, Ameeruddin Nusrath
    Subbian, Selvakumar
    Hanna, Luke Elizabeth
    Selvakumar, Nagamiah
    [J]. INFECTION GENETICS AND EVOLUTION, 2016, 45 : 474 - 492
  • [10] RESISTANCE TO RIFAMPICIN AND ISONIAZID IN STRAINS OF MYCOBACTERIUM-TUBERCULOSIS
    SIDDIQI, SH
    AZIZ, A
    REGGIARDO, Z
    MIDDLEBROOK, G
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 1981, 34 (08) : 927 - 929